Johanna Lahdenranta

Johanna Lahdenranta

Company: Bicycle Therapeutics

Job title: Director In Vivo Pharmacology


Exploring Tumor Localized CD137 Agonism with Bicycle Tumor-Targeted Immune Cell Agonists (Bicycle TICAs®) 12:15 pm

Description of the development of tumor-targeted immune cell agonists (Bicycle TICA™) based on constrained bicyclic peptides (Bicycles®) to activate costimulatory receptors selectively in the presence of tumor cells Outlining the preclinical mechanistic data underlying the profound reprogramming of the tumor immune microenvironment Highlighting translational aspects of work to inform clinical trialsRead more

day: Translation Track - Day 1 am

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.